This was 5/10 BlackSky backs prior FY23 revenue view $90M-$96M,consensus $94.21M 05/10 BKSY The Company anticipates strong global demand for BlackSky's products and services to continue throughout the year. As a result, the Company maintains its full year 2023 revenue outlook of between $90 million and $96 million, a 42% increase over 2022 revenue at the mid-point of this range. The Company remains on track to achieve positive Adjusted EBITDA in the fourth quarter of 2023. In addition, the Company maintains its expectations for full year 2023 capital expenditures to be between $40 million and $45 million.
$2.70 open on MBOT. Microbot Medical Inc. (MBOT) NasdaqCM - NasdaqCM Real Time Price. 2.0650-0.1250 (-5.7078%)